Table 4.
Relative expression levels of serum miR-1291 within the different subgroups of bullous pemphigoid (BP) patients.
| Subgroups | n = 45 | miR-1291 (2-ΔCt), median (IQR) | P value |
|---|---|---|---|
| Sex | |||
| Female | 20 | 0.52 (0.15-1.09) | 0.093 |
| Male | 25 | 0.25 (0.09-0.71) | |
| Hypertension | |||
| With | 14 | 0.30 (0.12-0.55) | 0.520 |
| Without | 31 | 0.31 (0.11-1.01) | |
| Cerebrovascular disease | |||
| With | 11 | 0.18 (0.08-0.63) | 0.255 |
| Without | 34 | 0.34 (0.15-1.02) | |
| Mucosal involvement | |||
| With | 10 | 0.45 (0.15-1.02) | 0.677 |
| Without | 35 | 0.31 (0.11-0.88) | |
| CCL17 | |||
| ≤549.0 pg/mL | 12 | 0.13 (0.08-0.24) | 0.009 |
| >549.0 pg/mL | 33 | 0.52 (0.16-1.03) | |
| Anti-BP180 | |||
| 0-9 U/mL | 7 | 0.63 (0.08-1.05) | 0.915 |
| >9 U/mL | 38 | 0.30 (0.14-0.81) | |
| Anti-BP230 | |||
| 0-9 U/mL | 20 | 0.23 (0.09-0.70) | 0.113 |
| >9 U/mL | 25 | 0.63 (0.15-1.09) |